LONDON (ShareCast) - (Sharecast News) - Tissue Regenix said on Tuesday that its computer systems and those of a third-party IT service provider in the US had been hit by a cyber attack.
The AIM-listed company, which makes regenerative medical devices, said it took immediate steps to respond to and manage the incident, appointing external specialists, including forensic cyber security experts to investigate the circumstances and scope.

These investigations are ongoing and the affected systems have been taken offline, it said.

"This has restricted access to certain business operations, including the company's ability in the short-term to continue manufacturing in its United States facility, which has been taken offline whilst the incident is being investigated. The incident is not believed to have impacted its UK operations or financial systems.

"The company is engaged with its third-party IT service provider, the relevant legal authorities and cyber security experts to rectify the incident as quickly as possible and to minimise any impact on its operations."

The group also said it is working to quantify the potential financial impact of the incident.

At 1115 GMT, the shares were down 11% at 1.09p.

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE